Capra Biosciences

Capra Biosciences

Private
Manassas, VirginiaHealthcare & Life Scienceshttp://www.caprabiosciences.com

Last Round

Grant

Jul 19, 2024

Total Funding Raised

$2.35M

Company Overview

Capra Biosciences is a biotechnology company that has developed a bioreactor platform to produce sustainable, bio-based chemicals as alternatives to petrochemicals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Fashion & Beauty, Circular Economy

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

synthetic biologysynbiobiomanufacturingbio-based chemicalsbioreactor platformpetrochemical replacementsbiofilm technologycontinuous biomanufacturingwaste-to-valueactive pharmaceutical ingredientsAPIretinolsalicylic acidgreen chemistrysustainable materialsmodular manufacturingindustrial lubricants

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Capra Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Capra Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 19, 2024
VC RoundApr 29, 2024
Pre SeedJun 6, 2022
SeedMar 17, 2021

Key People

Founding team and executive leadership

Elizabeth Onderko

Chief Executive Officer

Executive Team

Capra Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2025

    Partnering with ATCC, Virginia Tech, and Syracuse University on feedstock switching.

Capra Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Capra Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Capra Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersManassas, Virginia
Employee Range20
Year Founded2020
Last FundingJul 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.